Financial Gravity Asset Management, Inc. Nektar Therapeutics Transaction History

Financial Gravity Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.53 - $1.03 $0 - $1	1 New	1 $46,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $16 - $25	-1 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $15 - $19	1 New	1 $0
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $556 - $773	-33 Closed	0 $0
Q4 2019 Feb 28, 2020	SELL	$15.87 - $23.12 $15 - $23	-1 Reduced 2.94%	33 $22,000
Q3 2019 Oct 15, 2019	BUY	$16.91 - $36.27 $67 - $145	4 Added 13.33%	34 $1,000
Q2 2019 Jul 26, 2019	SELL	$31.0 - $36.3 $31 - $36	-1 Reduced 3.23%	30 $1,000
Q1 2019 Apr 19, 2019	SELL	$31.58 - $46.35 $9,568 - $14,044	-303 Reduced 90.72%	31 $1,000
Q3 2018 Oct 31, 2018	BUY	$46.46 - $68.49 $92 - $136	2 Added 0.6%	334 $12,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $14,198 - $32,066	307 Added 1228.0%	332 $20,000
Q1 2018 May 23, 2018	BUY	$57.4 - $108.44 $1,435 - $2,711	25 New	25 $2,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.